Skip to main content
. 2008 Sep 26;26(41):5269–5275. doi: 10.1016/j.vaccine.2008.07.040

Fig. 1.

Fig. 1

Serum levels of TGF-β1 protein are decreased in BCG primed subjects following boosting with MVA85A but not in subjects vaccinated with BCG alone or MVA85A alone. Serum TGF-β1 protein levels were measured on the day of vaccination and 1, 4 and 12 weeks post-vaccination for subjects vaccinated with BCG alone (n = 6), MVA85A alone (n = 8) and in BCG primed subjects vaccinated with MVA85A (n = 11). There was a significant decrease in serum TGF-β1 protein in BCG primed subjects following boosting with MVA85A, *p = 0.0005, **p = 0.021, ***p = 0.021 (Wilcoxon). Box and whisker plots showing median, 25th and 75th percentiles.